文献速递神经核医学

皮质下区域淀粉样蛋白沉积预测认知功能下降

Amyloid involvement in subcortical regions predicts cognitive decline.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-07-06

研究基于阿尔茨海默病神经影像学倡议(ADNI)数据,纳入240例认知正常老年人、393例轻度认知障碍和126例阿尔茨海默病患者,分析杏仁核、壳核和尾状核的淀粉样蛋白沉积,建立三阶段分期模型。结果显示淀粉样蛋白先沉积于皮质并向下蔓延至壳核、尾状核和杏仁核;纵向分析中,第2阶段(皮质及皮质下均受累)的MMSE、ADAS-cog 13、FDG PET SUVR和海马体积变化最陡峭,其次为第1阶段,再为第0阶段(p值<0.001)。

要点

  • 淀粉样蛋白沉积从新皮质开始,随后向下蔓延至壳核、尾状核和杏仁核。
  • 基于皮质下受累的三阶段分期中,第2阶段认知、功能和结构下降最快。
  • 纵向分析显示第2阶段较第1阶段MMSE、ADAS-cog 13、FDG PET SUVR和海马体积变化更陡峭。

核心结论

  • 淀粉样蛋白呈向下蔓延模式,即先在新皮质累积,随后累及皮质下结构。
  • 基于皮质下受累的淀粉样蛋白分期方案可能揭示不同区域淀粉样蛋白累积如何通过脑功能和结构改变影响认知下降。

研究设计与样本

  • 研究纳入来自阿尔茨海默病神经影像学倡议(ADNI)站点的240例认知正常老年人、393例轻度认知障碍参与者和126例阿尔茨海默病参与者。
  • 为评估皮质下受累,分析杏仁核、壳核和尾状核的淀粉样蛋白沉积。
  • 根据皮质和皮质下淀粉样蛋白受累情况将参与者分为3个阶段:382例无皮质或皮质下受累为第0阶段,165例有皮质但无皮质下受累为第1阶段,203例同时有皮质和皮质下受累为第2阶段。

主要发现

  • 淀粉样蛋白累积首先见于皮质区域,并向下蔓延至壳核、尾状核和杏仁核。
  • 纵向分析中,MMSE、ADAS-cog 13、FDG PET SUVR和海马体积的变化在第2阶段最陡峭,其次为第1阶段,再为第0阶段(p值<0.001)。
  • 与第1阶段相比,第2阶段MMSE评分变化更陡峭(β [SE] = -0.02 [0.004],p < 0.001)。
  • 与第1阶段相比,第2阶段ADAS-cog 13变化更陡峭(β [SE] = 0.05 [0.01],p < 0.001)。
  • 与第1阶段相比,第2阶段FDG PET SUVR变化更陡峭(β [SE] = -0.0008 [0.0003],p = 0.004),海马体积变化更陡峭(β [SE] = -4.46 [0.65],p < 0.001)。

关键数值与推荐

  • 第0阶段:无皮质或皮质下淀粉样蛋白受累(382例)。
  • 第1阶段:有皮质但无皮质下淀粉样蛋白受累(165例)。
  • 第2阶段:同时有皮质和皮质下淀粉样蛋白受累(203例)。
  • 第2阶段较第1阶段MMSE评分β [SE] = -0.02 [0.004],p < 0.001;ADAS-cog 13 β [SE] = 0.05 [0.01],p < 0.001;FDG PET SUVR β [SE] = -0.0008 [0.0003],p = 0.004;海马体积β [SE] = -4.46 [0.65],p < 0.001。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We estimated whether amyloid involvement in subcortical regions may predict cognitive impairment, and established an amyloid staging scheme based on degree of subcortical amyloid involvement. METHODS: Data from 240 cognitively normal older individuals, 393 participants with mild cognitive impairment, and 126 participants with Alzheimer disease were acquired at Alzheimer's Disease Neuroimaging Initiative sites. To assess subcortical involvement, we analyzed amyloid deposition in amygdala, putamen, and caudate nucleus. We staged participants into a 3-stage model based on cortical and subcortical amyloid involvement: 382 with no cortical or subcortical involvement as stage 0, 165 with cortical but no subcortical involvement as stage 1, and 203 with both cortical and subcortical involvement as stage 2. RESULTS: Amyloid accumulation was first observed in cortical regions and spread down to the putamen, caudate nucleus, and amygdala. In longitudinal analysis, changes in MMSE, ADAS-cog 13, FDG PET SUVR, and hippocampal volumes were steepest in stage 2 followed by stage 1 then stage 0 (p value <0.001). Stage 2 showed steeper changes in MMSE score (β [SE] = -0.02 [0.004], p < 0.001), ADAS-cog 13 (0.05 [0.01], p < 0.001), FDG PET SUVR (-0.0008 [0.0003], p = 0.004), and hippocampal volumes (-4.46 [0.65], p < 0.001) compared to stage 1. CONCLUSIONS: We demonstrated a downward spreading pattern of amyloid, suggesting that amyloid accumulates first in neocortex followed by subcortical structures. Furthermore, our new finding suggested that an amyloid staging scheme based on subcortical involvement might reveal how differential regional accumulation of amyloid affects cognitive decline through functional and structural changes of the brain.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Cho SH, Shin JH, Jang H, et al. Amyloid involvement in subcortical regions predicts cognitive decline. Eur J Nucl Med Mol Imaging. 2018. PMID: 29980831. doi:10.1007/s00259-018-4081-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。